Literature DB >> 24445903

Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability.

Malcolm Proudfoot1, Nick J Gutowski, Dieter Edbauer, David A Hilton, Mark Stephens, Julia Rankin, Ian R A Mackenzie.   

Abstract

Familial cases of frontotemporal dementia (FTD) provide an opportunity to study the pathophysiology of this clinically diverse condition. The C9ORF72 mutation is the most common cause of familial FTD, recent pathological descriptions challenge existing TDP-43 based hypotheses of sporadic FTD pathogenesis. Non-ATG dependent translation of the hexanucleotide expansion into aggregating dipeptide repeat (DPR) proteins may represent a novel pathomechanism. We report detection of the DPR aggregates very early in C9ORF72 FTD development and also describe childhood intellectual disability as a clinical feature preceding dementia. The index case presented with psychiatric symptoms, progressing into typical FTD. Autopsy revealed extensive neuronal DPR aggregates but only minimal TDP-43 pathology. Her intellectually disabled elder son, also carrying the C9ORF72 mutation, died aged 26 years and at autopsy only DPR aggregates without TDP-43 were found. A second son also has intellectual disability, his C9ORF72 status is unknown, but chromosomal microarray revealed no other cause of disability. These cases both extend the existing phenotype of C9ORF72 mutation and highlight the potential significance of DPR translation early in disease development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445903     DOI: 10.1007/s00401-014-1245-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.

Authors:  Annie Watson; Mochtar Pribadi; Kodavali Chowdari; Sue Clifton; Bruce L Miller; Giovanni Coppola; Vishwajit Nimgaonkar
Journal:  Psychiatry Res       Date:  2015-12-08       Impact factor: 3.222

Review 2.  Disease Mechanisms of C9ORF72 Repeat Expansions.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

3.  Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD.

Authors:  Thomas Westergard; Brigid K Jensen; Xinmei Wen; Jingli Cai; Elizabeth Kropf; Lorraine Iacovitti; Piera Pasinelli; Davide Trotti
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

Review 4.  Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms.

Authors:  Hannah E Silverman; Jill S Goldman; Edward D Huey
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

5.  C9ORF72 gene expansion in a patient with intellectual disability and psychiatric disease.

Authors:  Alba Rosa Pati; Carla Battisti; Stefania Battistini; Claudia Ricci; Antonella Trapassi; Roberto Marconi; Andrea Mignarri; Antonio Federico; Maria Teresa Dotti
Journal:  Neurol Sci       Date:  2016-09-19       Impact factor: 3.307

Review 6.  RNA-mediated toxicity in C9orf72 ALS and FTD.

Authors:  Zachary T McEachin; Janani Parameswaran; Nisha Raj; Gary J Bassell; Jie Jiang
Journal:  Neurobiol Dis       Date:  2020-08-21       Impact factor: 5.996

7.  Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia.

Authors:  Sarat C Vatsavayai; Soo Jin Yoon; Raquel C Gardner; Tania F Gendron; Jose Norberto S Vargas; Andrew Trujillo; Mochtar Pribadi; Joanna J Phillips; Stephanie E Gaus; John D Hixson; Paul A Garcia; Gil D Rabinovici; Giovanni Coppola; Daniel H Geschwind; Leonard Petrucelli; Bruce L Miller; William W Seeley
Journal:  Brain       Date:  2016-10-22       Impact factor: 13.501

8.  Fluid Biomarkers of Frontotemporal Lobar Degeneration.

Authors:  Emma L van der Ende; John C van Swieten
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.

Authors:  David J Irwin; Nigel J Cairns; Murray Grossman; Corey T McMillan; Edward B Lee; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-12-31       Impact factor: 17.088

10.  C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.

Authors:  Jacqueline G O'Rourke; Laurent Bogdanik; A K M G Muhammad; Tania F Gendron; Kevin J Kim; Andrew Austin; Janet Cady; Elaine Y Liu; Jonah Zarrow; Sharday Grant; Ritchie Ho; Shaughn Bell; Sharon Carmona; Megan Simpkinson; Deepti Lall; Kathryn Wu; Lillian Daughrity; Dennis W Dickson; Matthew B Harms; Leonard Petrucelli; Edward B Lee; Cathleen M Lutz; Robert H Baloh
Journal:  Neuron       Date:  2015-12-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.